Fremont CA – April 9, 2012 -- PEGylation has become a well-accepted method for the delivery of biopharmaceuticals-especially peptide and protein drugs.1-4 Simple modification of a drug with polyethylene glycol (PEG) not only is capable of improving the drug’s solubility, diminishing the potential for aggregation, and minimizing interference for both in vitro and in vivo applications, but is also able to protect it from proteolytic digestion, increasing its half-life in biological applications in the process.1-4
AnaSpec, EGT Group is pleased to highlight our wide collection of Fmoc- and Boc-protected PEGylated amino acids for PEGylated peptides synthesis. As well, custom synthesis of PEGylated peptides is available through our Fremont, California facilities. To obtain a price quotation, please email service@anaspec.com.
References
1. Veronese, FM. Biomaterials 22, 405 (2001).
2. Roberts, MJ. et al. Adv Drug Delivery Rev 54, 459 (2002).
3. Chapman, AP. Adv Drug Delivery Rev 54, 531 (2002).
4. DeFrees, S. et al. Glycobio 16, 833 (2006).
For more information, please visit http://www.anaspec.com/products/promotions.asp?id=99&col=2&row=2
AnaSpec, EGT Group
AnaSpec, Eurogentec Group is a leading provider of integrated proteomics and genomics solutionsTM for worldwide life science research. AnaSpec offers expertise in peptides, detection reagents, antibodies, assay kits, amino acids, oligonucleotides, and qPCRs. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. AnaSpec also provides premier custom services including peptide synthesis, antibody production, assay development, fluorescent dyes, and oligonucleotide synthesis. AnaSpec is certified to ISO 9001:2008.
For more information visit www.anaspec.com
